SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Omega Healthcare Investors Inc – ‘8-K’ for 3/3/21

On:  Thursday, 3/4/21, at 4:56pm ET   ·   For:  3/3/21   ·   Accession #:  1104659-21-32168   ·   File #:  1-11316

Previous ‘8-K’:  ‘8-K’ on 3/4/21 for 3/3/21   ·   Next:  ‘8-K’ on / for 3/10/21   ·   Latest:  ‘8-K’ on 4/14/21 for 4/8/21   ·   2 References:   

Magnifying glass tilted right emoji
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/04/21  Omega Healthcare Investors Inc    8-K:8,9     3/03/21   11:475K                                   Toppan Merrill/FA

Current Report   —   Form 8-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     30K 
 2: EX-1.1      Underwriting Agreement                              HTML    169K 
 7: R1          Cover                                               HTML     47K 
 9: XML         IDEA XML File -- Filing Summary                      XML     11K 
 6: XML         XBRL Instance -- tm218752d1_8k_htm                   XML     15K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.LAB  XBRL Labels -- ohi-20210303_lab                      XML     96K 
 5: EX-101.PRE  XBRL Presentations -- ohi-20210303_pre               XML     64K 
 3: EX-101.SCH  XBRL Schema -- ohi-20210303                          XSD     12K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               25±    34K 
11: ZIP         XBRL Zipped Folder -- 0001104659-21-032168-xbrl      Zip     49K 

‘8-K’   —   Current Report

This is an HTML Document rendered as filed.  [ Alternative Formats ]

 iX:   C:   C:   C:   C:   C:   C:   C:   C:   C: 
 i 0000888491  i false 0000888491 2021-03-03 2021-03-03 iso4217:USD xbrli:shares iso4217:USD xbrli:shares









FORM  i 8-K





Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934


Date of Report (Date of earliest event reported):  i March 3, 2021



(Exact name of registrant as specified in its charter)


 i Maryland  i 1-11316  i 38-3041398
(State or other jurisdiction of
(Commission File Number) (IRS Employer
Identification No.)


 i 303 International Circle

 i Suite 200

 i Hunt Valley,  i Maryland  i 21030

(Address of principal executive offices / Zip Code)


( i 410)  i 427-1700

(Registrant’s telephone number, including area code)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


   i ¨ Written communications pursuant to Rule 425 under the Securities Act.


   i ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act.


   i ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.


   i ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.


Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:


Title of each class Trading Symbol(s) Name of each exchange on which
 i Common Stock, $.10 par value  i OHI  i New York Stock Exchange


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).


Emerging growth company  i ¨


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨








Item 8.01 Other Events.


On March 3, 2021, Omega Healthcare Investors, Inc., a Maryland corporation (“Omega”), entered into an underwriting agreement (the “Underwriting Agreement”) with the representatives of the several underwriters named therein relating to the sale by Omega of $700,000,000 aggregate principal amount of 3.250% Senior Notes due 2033. The net proceeds from the offering, after deducting the underwriting discount but before deducting estimated offering expenses payable by Omega, are expected to be approximately $690.4 million, which Omega intends to use (i) to repay its British Pounds Sterling denominated borrowings under its credit facilities and (ii) to fund the purchase price for its previously announced tender offer to purchase for cash a portion of its 4.375% Senior Notes due 2023 and the payment of accrued interest and related fees, premiums and expenses in connection therewith. Omega intends to use any remaining net proceeds, including in the event that it does not achieve full participation in the tender offer, to repay a portion of outstanding borrowings under its credit facilities and for general corporate purposes, which may include future acquisition or investment opportunities.


The foregoing is a summary description of certain terms of the Underwriting Agreement and is qualified in its entirety by reference to the Underwriting Agreement, which is filed as Exhibit 1.1 to this Current Report on Form 8-K and is incorporated herein by reference.


Item 9.01 Financial Statements and Exhibits.


(d) Exhibits. The following exhibits are being filed herewith:


No.   Description
1.1   Underwriting Agreement, dated March 3, 2021, by and among Omega and the representatives of the underwriters named therein.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)







Pursuant to the requirements of the Securities Exchange Act of 1934, the co-registrants have duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Dated: March 4, 2021 By: /s/ Gail D. Makode
    Gail D. Makode
    Chief Legal Officer, General Counsel and Secretary





Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on:3/4/218-K
For Period end:3/3/21424B5,  8-K,  FWP
 List all Filings 

2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/05/21  Omega Healthcare Investors Inc    424B5                  1:674K                                   Toppan Merrill/FA
 3/05/21  Omega Healthcare Investors Inc    424B5                  1:673K                                   Toppan Merrill/FA
Filing Submission 0001104659-21-032168   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2021 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 18, 11:32:26.0am ET